Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Mortality in Norway and Sweden before and after the Covid-19 outbreak: a cohort study

View ORCID ProfileFrederik E Juul, View ORCID ProfileHenriette C Jodal, View ORCID ProfileIshita Barua, View ORCID ProfileErle Refsum, Ørjan Olsvik, View ORCID ProfileLise M Helsingen, View ORCID ProfileMagnus Løberg, View ORCID ProfileMichael Bretthauer, View ORCID ProfileMette Kalager, View ORCID ProfileLouise Emilsson
doi: https://doi.org/10.1101/2020.11.11.20229708
Frederik E Juul
1Clinical Effectiveness Research Group, Oslo University Hospital and University of Oslo, Oslo, Norway
Roles: medical doctor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Frederik E Juul
  • For correspondence: f.e.juul{at}medisin.uio.no
Henriette C Jodal
1Clinical Effectiveness Research Group, Oslo University Hospital and University of Oslo, Oslo, Norway
Roles: medical doctor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Henriette C Jodal
Ishita Barua
1Clinical Effectiveness Research Group, Oslo University Hospital and University of Oslo, Oslo, Norway
Roles: medical doctor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ishita Barua
Erle Refsum
1Clinical Effectiveness Research Group, Oslo University Hospital and University of Oslo, Oslo, Norway
Roles: postdoctoral fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erle Refsum
Ørjan Olsvik
2Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromso, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lise M Helsingen
1Clinical Effectiveness Research Group, Oslo University Hospital and University of Oslo, Oslo, Norway
Roles: medical doctor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lise M Helsingen
Magnus Løberg
1Clinical Effectiveness Research Group, Oslo University Hospital and University of Oslo, Oslo, Norway
Roles: associate professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Magnus Løberg
Michael Bretthauer
1Clinical Effectiveness Research Group, Oslo University Hospital and University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Bretthauer
Mette Kalager
1Clinical Effectiveness Research Group, Oslo University Hospital and University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mette Kalager
Louise Emilsson
1Clinical Effectiveness Research Group, Oslo University Hospital and University of Oslo, Oslo, Norway
3Department of General Practice, University of Oslo, Oslo, Norway
4Vårdcentralen Årjäng & Centre for Clinical Research, Värmland län, Sverige
5Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
Roles: associate professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Louise Emilsson
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives Norway and Sweden are similar countries regarding ethnicity, socioeconomics and health care. To combat Covid-19, Norway implemented extensive measures such as school closures and lock-downs, while Sweden has been criticised for relaxed measures against Covid-19. We compared the effect of the different national strategies on all-cause and Covid-19 associated mortality.

Design Retrospective cohort.

Setting The countries Norway and Sweden.

Participants All inhabitants.

Main outcome measures We calculated weekly mortality rates (MR) with 95% confidence intervals (CI) per 100,000 individuals as well as mortality rate ratios (MRR) comparing the epidemic year (29th July, 2019 to 26th July, 2020) to the four preceding years (July 2015 to July 2019). We also compared Covid-19 associated deaths and mortality rates for the weeks of the epidemic in Norway and Sweden (16th March to 26th July, 2020).

Results In Norway, mortality rates were stable during the first three 12-month periods of 2015/16; 2016/17 and 2017/18 (MR 14.8 to 15.1 per 100,000), and slightly lower in the two most recent periods including during epidemic period (2018/19 and 2019/20; 14.5 per 100,000). In Sweden, all-cause mortality was stable during the first three 12-month periods of 2015/16; 2016/17 and 2017/18 (MR 17.2 to 17.5 per 100,000), but lower in the year 2018/19 immediately preceding the epidemic (16.2 per 100,000). Covid-19 associated mortality rates were 0.2 per 100,000 (95%CI 0.1 to 0.4) in Norway and 2.9 (95%CI 1.9 to 3.9) in Sweden. The increase in mortality was confined to individuals in 70 years or older.

Conclusions All-cause mortality remained unaltered in Norway. In Sweden, the observed increase in all-cause mortality during Covid-19 was partly due to a lower than expected mortality preceding the epidemic and the observed excess mortality, was followed by a lower than expected mortality after the first Covid-19 wave. This may suggest mortality displacement.

Strengths and limitations of this study

  1. Compares two similar contries in all aspects but the handling of the Covid-19 epidemic

  2. Evaluates the mortality for several years before and during the epidemic

  3. Provides a possible explanation of the observed mortality changes

  4. Discusses the socioeconomic effects of the different strategies in the two countries

  5. Does not evaluate cause-specific mortality

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the Norwegian Research Council (Project number 312757), Norwegian Cancer Society (Project number 190345). The funding sources had no role in the design, conduct or reporting of the study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All data analysed in this report are publicly available, and no ethical approval was needed.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data analysed in this report are publicly available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 13, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Mortality in Norway and Sweden before and after the Covid-19 outbreak: a cohort study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mortality in Norway and Sweden before and after the Covid-19 outbreak: a cohort study
Frederik E Juul, Henriette C Jodal, Ishita Barua, Erle Refsum, Ørjan Olsvik, Lise M Helsingen, Magnus Løberg, Michael Bretthauer, Mette Kalager, Louise Emilsson
medRxiv 2020.11.11.20229708; doi: https://doi.org/10.1101/2020.11.11.20229708
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Mortality in Norway and Sweden before and after the Covid-19 outbreak: a cohort study
Frederik E Juul, Henriette C Jodal, Ishita Barua, Erle Refsum, Ørjan Olsvik, Lise M Helsingen, Magnus Løberg, Michael Bretthauer, Mette Kalager, Louise Emilsson
medRxiv 2020.11.11.20229708; doi: https://doi.org/10.1101/2020.11.11.20229708

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3298)
  • Dentistry and Oral Medicine (365)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
  • Epidemiology (13384)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5157)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3274)
  • Health Policy (1143)
  • Health Systems and Quality Improvement (1193)
  • Hematology (432)
  • HIV/AIDS (1019)
  • Infectious Diseases (except HIV/AIDS) (14636)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (478)
  • Medical Ethics (127)
  • Nephrology (525)
  • Neurology (4930)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (886)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (727)
  • Orthopedics (282)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (544)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4218)
  • Public and Global Health (7511)
  • Radiology and Imaging (1708)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (549)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)